Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000936392-08-000558
Filing Date
2008-08-21
Accepted
2008-08-21 11:07:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO SCHEDULE 13D a43198sc13dza.htm SC 13D/A 21892
  Complete submission text file 0000936392-08-000558.txt   23939
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10505 ROSELLE STREET SAN DIEGO CA 92121 858-558-4850
SGX PHARMACEUTICALS, INC. (Subject) CIK: 0001125603 (see all company filings)

EIN.: 061523147 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-81448 | Film No.: 081031487
SIC: 2834 Pharmaceutical Preparations